The strategy, slated to be released this week, aims to increase use of the drug, which can prevent hospitalizations among people at high risk for severe COVID-19. The White House will encourage clinicians to err on the side of prescribing the antiviral instead of rationing the drug, as many have done since its FDA approval in December, when supplies were initially low.
“We’re working to make sure doctors and patients know about Paxlovid,” White House spokesperson Karine Jean-Pierre told Bloomberg. “It’s widely available, and the eligibility criteria are pretty expansive.”
Nationwide, about 20,000 pharmacy locations stock Paxlovid. The White House plans to allow any pharmacy to order the drug directly from the federal government, the official told Bloomberg.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
